Presbyopia: 40+ patients need a new approach. · The Monday Briefing, 3 August 2026

August 3, 2026  ·  Weekly Newsletter

Good morning, Reader.

This week, the call for personalised presbyopia treatment challenges the ophthalmology sector: why are we still aiming for one-size-fits-all solutions when patient satisfaction is clearly suffering? The disconnect between available interventions and actual visual quality highlights a persistent gap in managing age-related near vision loss for those over 40. It matters.

1. **Presbyopia personalisation**, Current intraocular lenses often fail to meet patient expectations for visual quality. Clinicians need to move beyond standard approaches for presbyopia correction. 2. **Environmental health impact**, Heatwaves increase EMS calls for COPD, unconsciousness, and trauma. Cancer care also demands environmental integration to ensure patient safety. 3. **Nicotine and tendon repair**, Vapes and nicotine pouches increase the risk of complications and re-rupture after Achilles tendon repair. This extends beyond smoking.

The pattern emerging is clear: generic approaches are failing in both treatment efficacy and patient outcomes, while external environmental factors and lifestyle choices exert a growing, often unrecognised, influence on disease progression and recovery. We are seeing the limits of isolated clinical thinking.

Clinicians must now consider the patient's entire context, not just the presenting condition.

I read every reply.

Cataract

Presbyopia, the age-related loss of near focusing ability, affects nearly everyone over 40, presenting a significant challenge for ophthalmologists aiming to restore functional vision. While various surgical and optical interventions exist, patient satisfaction remains highly variable, often due to unmet expectations regarding visual quality and freedom from spectacles. The current landscape of presbyopia correction, particularly with intraocular lenses (IOLs), demands a more nuanced approach…